第一作者机构：[1]Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Ran Ran,Li Hongtao,Zhou Huan,et al.A phase Ib study of JMT103, a receptor activator of NF-kB ligand (RANKL) antibody, in patients (pts) with bone metastases from solid tumors[J].JOURNAL OF CLINICAL ONCOLOGY.2024,42(16):
APA：
Ran, Ran,Li, Hongtao,Zhou, Huan,Sun, Tao,Zang, Ai-min...&Li, Jin.(2024).A phase Ib study of JMT103, a receptor activator of NF-kB ligand (RANKL) antibody, in patients (pts) with bone metastases from solid tumors.JOURNAL OF CLINICAL ONCOLOGY,42,(16)
MLA：
Ran, Ran,et al."A phase Ib study of JMT103, a receptor activator of NF-kB ligand (RANKL) antibody, in patients (pts) with bone metastases from solid tumors".JOURNAL OF CLINICAL ONCOLOGY 42..16(2024)
医学